|
|
You are searching for "CFAMM00421369" in compound. Total 1 results found.
Click on CFAM IDs and names to search or view in CFAM, click on external IDs to view the entity in its source database.
CFAM Mol ID | CFAMM00421369 |
Family | CFFBM13250 C-C chemokine receptor type 1 and Chemokine (C-C motif) receptor 1 ligand [2-[(2S)-3-(5-chlorospiro[3H-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-4-hydroxyphenyl]-[(3R)-3-hydroxypyrrolidin-1-yl]methanone family |
Superfamily | CFSBM5998 Cyclin-dependent kinase 1 and Cyclin-dependent kinase 2 Binder Superfamily |
Class | CFCAD288 Class 288 |
External ID | CHEMBL2391795 |
External Source | CHEMBL |
PubChem CID |
10367570 |
Functional Category |
Bioactive |
Molecule Name |
2-[(2S)-3-(5-chlorospiro[3H-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-N-cyclopropyl-4-hydroxybenzamide |
IUPAC Name |
2-[(2S)-3-(5-chlorospiro[3H-1-benzofuran-2,4'-piperidine]-1'-yl)-2-hydroxypropoxy]-N-cyclopropyl-4-hydroxybenzamide |
Synonyms |
SureCN4224131 |
InChi |
InChI=1S/C25H29ClN2O5/c26-17-1-6-22-16(11-17)13-25(33-22)7-9-28(10-8-25)14-20(30)15-32-23-12-19(29)4-5-21(23)24(31)27-18-2-3-18/h1,4-6,11-12,18,20,29-30H,2-3,7-10,13-15H2,(H,27,31)/t20-/m0/s1 |
InChiKey |
QUWFBAJQLUHXBF-FQEVSTJZSA-N |
Formula | C25H29ClN2O5 |
Molecular Weight | 472.96 |
Cross Link | CHEMBL2391795 |
Structure |
|
Statistics of CFAM Database |
CFAM currently contains 490,279 molecules in 87,136 families, 34,880 superfamilies and 11,643 classes. |
How to cite our database |
C. Zhang, L. Tao, C. Qin, P. Zhang, S.Y. Chen, X. Zeng, F. Xu, Z. Chen, S.Y. Yang and Y.Z. CFam: A Chemical Families Database Based on Iterative Selection of Functional Seeds and Seed-Directed Compound Clustering.
Nucl. Acids Res. 43 (D1): D558-D565 (2015) (First published online: November 20, 2014).
|
Last update by |
2014.08.29
|
48716 visits since 2014 .........
Dr.
Chen Yuzong
Deputy
Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|